Takeda reorganizes top leadership, corporate structure

Takeda has outlined plans to reorganize the company under a new leadership group. The new structure includes Koichi Kamiyama as the director of the newly dubbed strategic production department, which replaces the old "Product Planning & Administration Department." As part of the restructuring, the "Overseas Project Management Department" is being dissolved and its current job responsibility is transferred to the strategic production department. Takeda has been watched closely in recent weeks after the shakeup pushed Millennium Pharmaceuticals' Deborah Dunsire to leave the company. Staffers have been waiting on an expected cutback. Release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.